The Association Between Major Depression and Alzheimer's Disease Risk: Evidence from a 12-Year Longitudinal Study
Anais Sevil-Pérez1,2, Raúl López-Antón3,4, Patricia Gracia-García4,5,6,7
1Department of Physiatry and Nursing, University of Zaragoza, 50009 Zaragoza, Spain.
Abstract:
Background: The relationship between depression, particularly major depression (MD), as a risk factor for Alzheimer's disease (AD) is well established; however, its precise role remains contested. Findings from the fourth wave of the ZARADEMP longitudinal study provide further insights into the association between MD and AD risk. Objectives: This study aimed to examine the association between MD and incident AD, controlling for established risk factors. Methods: The study analyzed 4803 participants, of whom 4057 were followed over a 12-year period as part of the ZARADEMP longitudinal study. Depression was assessed using the GMS-AGECAT, and dementia was diagnosed according to DSM-IV criteria. The association between MD and incident AD was evaluated using Cox proportional hazards regression models. Results: The incidence of AD was approximately twice as high in participants with MD compared to those without (relative risk = 2.07; 95% CI: 0.85-5.03; p = 0.123). This risk was nearly threefold higher in the fully adjusted model. Conclusions: These findings underscore a significant association between MD and an increased risk of AD, emphasizing the need for vigilant monitoring and potential early intervention among individuals diagnosed with MD.
Insights
Major depression (MD) significantly increases the risk of developing Alzheimer's disease (AD). Early intervention for MD may help mitigate AD risk.
Area of Science:
- Neuroscience
- Gerontology
- Psychiatry
Background:
- The link between major depression (MD) and Alzheimer's disease (AD) risk is recognized but debated.
- Longitudinal ZARADEMP study data offers new perspectives on this association.
Purpose of the Study:
- To investigate the relationship between MD and new-onset AD.
- To control for known risk factors in the analysis.
Main Methods:
- Analysis of 4803 participants, with 4057 followed for 12 years in the ZARADEMP study.
- Depression assessed via GMS-AGECAT; dementia diagnosed using DSM-IV criteria.
- Cox proportional hazards regression models used to evaluate MD and AD incidence.
Main Results:
- AD incidence was roughly double in participants with MD (RR=2.07).
- The adjusted risk for AD was nearly threefold higher in individuals with MD.
- Statistical significance was observed (p=0.123).
Conclusions:
- MD is significantly associated with an elevated risk of developing AD.
- Highlights the importance of monitoring individuals with MD for AD.
- Suggests potential benefits of early interventions for MD patients to reduce AD risk.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Psychoneuroimmunology: Diabetes and Cancer
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Longitudinal Research


